|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
29-30
|
|
pubmed:dateCreated |
2008-7-25
|
|
pubmed:abstractText |
The effectiveness of lipid-lowering medication critically depends on the patients' compliance and the efficacy of the prescribed drug.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1424-7860
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
26
|
|
pubmed:volume |
138
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
420-6
|
|
pubmed:dateRevised |
2011-2-15
|
|
pubmed:meshHeading |
pubmed-meshheading:18654867-Aged,
pubmed-meshheading:18654867-Female,
pubmed-meshheading:18654867-Fluorobenzenes,
pubmed-meshheading:18654867-Humans,
pubmed-meshheading:18654867-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:18654867-Hypercholesterolemia,
pubmed-meshheading:18654867-Lipoproteins, LDL,
pubmed-meshheading:18654867-Male,
pubmed-meshheading:18654867-Middle Aged,
pubmed-meshheading:18654867-Patient Compliance,
pubmed-meshheading:18654867-Pyrimidines,
pubmed-meshheading:18654867-Sulfonamides,
pubmed-meshheading:18654867-Switzerland,
pubmed-meshheading:18654867-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia.
|
|
pubmed:affiliation |
Institute für Klinische Chemie & Haematologie und, Klinische Mikrobiologie & Immunologie, Kantonsspital, St. Gallen, Switzerland. walter.riesen@ikch.ch
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
